Researchers synthesize protein critical to red blood cell production

Nov 12, 2012
Researchers synthesize protein critical to red blood cell production

(Phys.org)—Researchers in the group of Centennial Professor of Chemistry, Samuel Danishefsky, have synthesized what is arguably the largest and most complex biological molecule ever assembled by the methods of organic chemistry.   The molecule is a version of erythropoietin (EPO), a protein critical to the production of red blood cells in mammals and consisting of a folded chain of 166 amino acids with carbohydrates attached at well-defined sites along the chain.

Professor Danishefsky's group includes researchers at Columbia and in the and Chemistry Program at Sloan-Kettering Institute, where Professor Danishefsky is the incumbent of a Eugene W. Kettering Chair.   His group's work on this project was assisted by enabling advances made by Dr. Xianping Tan of Professor Virginia Cornish's group at Columbia and by Dr. Gong Chen in the Columbia group of Professor Dalibor Sames.

Naturally occurring erythropoietin is actually a highly complex family of molecules, all of which have the same basic and which differ only in the nature of the attached carbohydrates.   The Danishefsky synthesis produces the exact with truncated forms of the carbohydrates attached at the correct locations and with the correct bonding mechanisms.   In vitro experiments demonstrate that the synthesized EPO is capable of stimulating the production of

The Danishefsky effort represents the first time a homogenous form of native EPO containing all of the carbohydrates has been obtained. The ability to create a unique variant of EPO, rather than the mix of EPO structures that occur naturally, is a breakthrough that points to eventual progress at systematically isolating, testing, and understanding the behavior of each variant.     It also provides a path to address a general question that has potential therapeutic significance  — namely, why does nature produce mixtures of proteins with a unique, underlying structure but which vary only in the nature of a small number of attached carbohydrates?

The new synthesis, which was originally reported online in Angewandte Chemie, has subsequently been covered in Science, the Royal Society of Chemistry's Chemistry World, and C & E News and it will also be reported in Nature.  The work is recognized asa breakthrough not only for its success at synthesizing EPO but also for the new techniques developed by the Danishefsky group for fabricating the segments of the EPO structure, for linking them together, and for bonding the carbohydrates at the correct locations.   The work represents an effort by the group that started in 2002.

Explore further: Jumping hurdles in the RNA world

More information: Angew. Chem. Int. Ed. 51, 1 -10, 2012;
Science 338, 28, Oct. 2012;
RSC Chemistry World, Oct. 10, 2012;
C & E News 90, 41, 11, Oct 8, 2012

Related Stories

First successful total synthesis of Erythropoietin

Oct 15, 2012

(Phys.org)—"Blood is quite a peculiar kind of juice"—that is what Mephisto knew, according to Goethe's "Faust". But if blood really is very special, then erythropoietin (EPO) must be a very special molecule, ...

A new way to boost red blood cell numbers

Jan 10, 2008

A common treatment for anemia — a deficiency in red blood cells (rbcs) caused by their insufficient production, excessive destruction, or excessive loss — is administration of recombinant erythropoietin (Epo), a hormone ...

The doping-drug Epo has an impact in the brain

Jun 11, 2012

Sportsmen and women dope with the blood hormone Epo to enhance their performance. Researchers from the University of Zurich now discovered by animal testing that Epo has a performance-enhancing effect in the brain shortly ...

Anemia drugs under scrutiny

Mar 13, 2008

U.S. drug regulators are contemplating further restrictions on the use of drugs to combat anemia in cancer patients.

Recommended for you

Jumping hurdles in the RNA world

Nov 21, 2014

Astrobiologists have shown that the formation of RNA from prebiotic reactions may not be as problematic as scientists once thought.

New computer model sets new precedent in drug discovery

Nov 18, 2014

A major challenge faced by the pharmaceutical industry has been how to rationally design and select protein molecules to create effective biologic drug therapies while reducing unintended side effects - a challenge that has ...

Finding new ways to make drugs

Nov 18, 2014

Chemists have developed a revolutionary new way to manufacture natural chemicals and used it to assemble a scarce anti-inflammatory drug with potential to treat cancer and malaria.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.